CMET-22. INTRATHECAL (IT) TRAZTUZUMAB (T) FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES (LM) IN PATIENTS (PTS) WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-POSITIVE (HER2+) CANCER: A MULTICENTER PHASE 1/2 STUDY

Bibliographic Details
Title: CMET-22. INTRATHECAL (IT) TRAZTUZUMAB (T) FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES (LM) IN PATIENTS (PTS) WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-POSITIVE (HER2+) CANCER: A MULTICENTER PHASE 1/2 STUDY
Authors: Kumthekar, Priya, Gradishar, William, Lin, Nancy, Pentsova, Elena, Groves, Morris, Jeyapalan, Suriya, Melisko, Michelle, Grimm, Sean, B. Lassman, Andrew, Raizer, Jeffrey
Source: Neuro-oncology. 20(suppl 6):vi58-vi58
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100094743406.0x000001&indx=1&recIds=ETOCvdc_100094743406.0x000001
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:15228517
Published in:Neuro-oncology
Language:English